The FDA granted the approval following findings from the pivotal POETYK PsA-I and POETYK PsA-II Phase III studies.

In 2019, BMS made a big bet on Sotyktu by deciding to keep the then-pipeline asset despite its pending acquisition of Celgene. Based on that decision, BMS sold its mega-blockbuster Otezla to Amgen for ...

Dr Philip Mease shares his clinical insights for diagnosing and treating fibromyalgia and psoriatic arthritis.

Key Summary The transition from psoriasis to psoriatic arthritis (PsA) is driven by several modifiable risk factors, ...

A t first glance, psoriasis is a skin disease: Skin symptoms likely led to your diagnosis, and if you’ve dealt with the stigma of psoriasis from others, it was probably because of visible skin lesions ...

Investigators recently examined clinical risk factors in the context of novel molecular biomarkers to predict progression of psoriasis to PsA. Nail involvement was found to be a strong predictor of ...

Dual therapy with a GLP-1 receptor agonist plus ixekizumab demonstrates long-term benefits in psoriatic disease activity, ...

The results from two recent clinical trials reinforce that treating obesity alongside inflammation can improve quality of life for many people with psoriatic diseases. In clinical trials involving ...

The main drivers of fatigue in patients with psoriasis and psoriatic arthritis were joint pain intensity, itch severity, and psoriasis severity. Researchers found an association between psoriasis, ...

Psoriatic arthritis is an autoimmune condition that causes joint problems alongside psoriasis. It can affect just about any joint in your body, including your knees. There is no cure, but there are ...

If you have an autoimmune disorder like psoriatic arthritis, you’re also at higher risk for neurological and psychiatric conditions. Experts think this may be because the inflammation that causes your ...